ask="2.24"
ask_size="1400"
average_daily_volume="2835120"
bid="2.18"
bid_size="2500"
book_value="4.53"
change="+0.01"
change_from_200_day_moving_average="-0.63"
change_from_50_day_moving_average="-0.00"
change_from_52_week_high="-1.63"
change_From_52_week_low="0.28"
change_in_percent="+0.45%"
close="2.21"
dividend_pay_date="6/13/2016"
dividend_per_share="0.20"
dividend_yield="9.09"
earnings_per_share="1.06"
ebitda="244.51M"
eps_estimate_current_year="0.54"
eps_estimate_next_quarter="0.07"
eps_estimate_next_year="0.20"
ex_dividend_date="6/2/2016"
float_shares="149792000"
high="2.21"
high_52_weeks="3.84"
last_trade_date="2/3/2017"
last_trade_price="2.21"
last_trade_size="168489"
last_trade_time="4:00pm"
low="2.18"
low_52_weeks="1.93"
market_capitalization="365.84M"
moving_average_200_day="2.84"
moving_average_50_day="2.21"
name="PDL BioPharma
Inc."
notes="N/A"
one_year_target_price="3.67"
open="2.21"
pe_ratio="2.09"
peg_ratio="0.29"
percent_change_from_200_day_moving_average="-22.31%"
percent_change_from_50_day_moving_average="-0.05%"
percent_change_from_52_week_high="-42.45%"
percent_change_from_52_week_low="+14.51%"
previous_close="2.20"
price_eps_estimate_current_year="4.09"
price_eps_Estimate_next_year="11.05"
price_per_book="0.49"
price_per_sales="1.27"
revenue="286.16M"
shares_outstanding="165540000"
short_ratio="3.78"
stock_exchange="NMS"
symbol="PDLI"
volume="1134573"
weeks_range_52="1.93 - 3.84"
